News and media

Discover the latest news about motor neurone disease (MND) advocacy and research or visit our one-stop-shop for media, Media hub.

Got a story to share? Tell us about how MND has impacted your life.

News List

RSS Feed RSS Icon
Default news teaser image
10th MND Australia Conference: Abstracts open

Morag Millington | 9/02/2021

The MND Australia Conference focuses on improving care and support for people living with MND.

Default news teaser image
MND Australia announces the appointment of new CEO: ​MEDIA RELEASE

Morag Millington | 25/11/2020

The Board of MND Australia is delighted to announce the appointment of David Ali as its new Chief Executive Officer.

Default news teaser image
MND Research Australia 2021 grants announced

Morag Millington | 24/11/2020

We are pleased to announce that our research arm, MND Research Australia, has awarded close to $3 million in grants for MND research commencing in 2021.

Default news teaser image
Stentrode success in early feasibility study

Morag Millington | 30/10/2020

We were delighted to learn this week that an early feasibility study of the Stentrode brain implant has successfully shown that it can aid people living with paralysis, such as those with MND, to continue to maintain communication. MND Research Australia funded early research into development of this device. 

Default news teaser image
Response to the federal Budget 2020-2021

Morag Millington | 13/10/2020

While MND Australia welcomes the much needed investments in aged care, health, disability & research handed down in the Budget, we believe that significant further funding is still required in these sectors. 

Default news teaser image
A new inflammatory pathway in MND

Carol Birks | 8/10/2020

A recent publication by MNDRA-funded Melbourne researchers has identified an immune pathway that may play a key role in the neuroinflammation seen in MND and present a novel target for developing new treatments.

They found that by blocking an immune sensor called STING, they could dramatically prevent inflammation from MND patient cells, paving the way for a new class of drugs to be developed for people with neurodegenerative disorders, such as MND.

New edition of the International Research Update now available
New edition of the International Research Update now available

Laura Birks | 23/09/2020

The September edition of MND Australia's International Research Update is now available. 

Default news teaser image
Results from stage 2 trial of AMX0035

Morag Millington | 3/09/2020

We welcome the publication today of results from the CENTAUR stage 2 clinical trial of AMX0035 (Tauroursodeoxycholic Acid and Sodium Phenylbutyrate) for the treatment of MND/ALS progression.


Proud member of:

International Alliance of ALS/MND Associations

ACNC Registered Charity


MND Australia would like to advise Aboriginal and Torres Strait Islander users that this website may contain images or names of deceased persons.